BioIT Worlds public
[search 0]
More
Download the App!
show episodes
 
Bio-IT World’s Trends from the Trenches podcast delivers your insider’s look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders. BioTeam co-founder Stan Gloss brings years of industry experience in science, data, and technology to conversations exploring what is driving data and discovery, and what’s coming next.
  continue reading
 
Loading …
show series
 
In this special transition episode of Trends from the Trenches, Ari Berman, CEO of BioTeam, takes the mic as the new host of the Trends from the Trenches podcast and speaks with founding host Stan Gloss, co-founder of BioTeam. During their conversation, they cover Stan’s journey as an entrepreneur, including the valuable lessons learned along the w…
  continue reading
 
In the first Trends from the Trenches episode of 2025, host Stan Gloss and Dirk Petersen, Director of Supercomputing Center at Oregon State University, talk about the state and role of HPCs in a world that’s focused on AI. Petersen offers his thoughts and insights on working with AI teams, how to converge the traditional HPC user with the AI user, …
  continue reading
 
In this episode of Trends from the Trenches, host Stan Gloss and Renee Iacona, vice president of Oncology Biometrics, Oncology R&D at AstraZeneca, discuss the process of matching patients with the right treatments, data management (particularly around oncology), and the value of knowledge graphs. Iacona mentions the importance of having scientists …
  continue reading
 
In this episode of Trends from the Trenches, host Stan Gloss discusses high-performance computing and its progress over the years with Rémy Evard, chief digital officer and head of technology at Memorial Sloan Kettering Cancer Center (MSK). They delve into the impact of cloud technology, the rapid development of AI (and the overexcitement around it…
  continue reading
 
In this episode of Trends from the Trenches, host Stan Gloss speaks with industry veteran Tom Plasterer, managing director of life sciences innovation at XponentL Data. Plasterer shares his journey of how he became an industry leader, how his time at BG Medicine (then known as Beyond Genomics) helped him with his time at AstraZeneca, what graph tec…
  continue reading
 
In this episode of Trends from the Trenches, host Stan Gloss speaks with Howard Jacob, vice president of genomics research at AbbVie. They discuss Jacob’s beginnings at AbbVie, data siloing and “my data vs. our data” issues, and the role of funding in plan execution and leadership support. Jacob also delves into the origins of the AbbVie R&D Conver…
  continue reading
 
Tune into this month’s episode of Trends from the Trenches, where host Stan Gloss and Ruth Marinshaw, CTO of Research Computing at Stanford University, talk about the accomplishments and challenges of supporting a diverse population of researchers in academia. Marinshaw also delves into building a reliable and trustworthy service, computational inf…
  continue reading
 
In this special episode of the Trends from the Trenches podcast, listen in on the Trends from the Trenches session at this year’s Bio-IT World Conference & Expo. Ari Berman, PhD, CEO of BioTeam, delivers a candid talk about the technologies driving data-intensive science, from the most worthwhile to the most overhyped to the most relevant. Learn wh…
  continue reading
 
In this month’s episode of Trends from the Trenches, host Stan Gloss speaks with Joseph La Barge. La Barge trained as an attorney but has spent most of his career building biotech businesses and securing funding. He shepherded Spark Therapeutics through its acquisition by Roche and has since joined Apertura Gene Therapy as CEO. He and Stan talk abo…
  continue reading
 
Change can be scary, but it can also bring new opportunities and lead to growth and innovation. In this episode of Trends from the Trenches, host Stan Gloss from BioTeam and Adama Ibrahim, VP of Digital Strategy & Change Management at Novo Nordisk, delve into a conversation about humanity’s natural resistance to change, why it is important to overc…
  continue reading
 
It’s no secret that the industry is drowning in data. That’s why data management strategies are needed now more than ever to speed up discoveries and bring new solutions to the market. In this episode of Trends from the Trenches, host Stan Gloss discusses data management strategies with Becky Upton, Ph. D., President of Pistoia Alliance. Dr. Upton …
  continue reading
 
Going from one field to the next can be a tricky thing to navigate. In this episode of Trends from the Trenches, host Stan Gloss speaks with Tom Miller, Co-Founder and CEO of Iambic Therapeutics, about his journey from academia as a professor at the California Institute of Technology to getting B-Round funding as the CEO of his own start-up. Miller…
  continue reading
 
In this episode of Trends from the Trenches, host Stan Gloss speaks with Heidi Rehm, PhD, Chair Elect of the Global Alliance for Genomics and Health (GA4GH), about data sharing policies and standards that can advance both genomics and health. Rehm discusses the benefits of data sharing on a global scale, how organizations can reduce friction of peo…
  continue reading
 
In the latest episode of the Trends from the Trenches podcast, host Stan Gloss and Bryn Roberts, PhD, Global Head of Data & Analytics at Roche Information Solutions explore the Why and the How behind AI. What used to be “happily left a bit in the background” is now main stage thanks to everyone’s new interest in ChatGPT. Roberts recommends applying…
  continue reading
 
After the “magical moment of hope” when the first human genome was sequenced, Jeanne Kehren switched from veterinary medicine to the pharmaceutical industry. Today, she is the SVP of Digital & Commercial Innovation and CIO at Bayer Pharmaceuticals and works in various areas, including sustainability, digital health, and digital transformation. In t…
  continue reading
 
A few years ago, artificial intelligence was in its developmental stages. Today, it is widely used by various industries and several companies are exploring new ways to utilize its tremendous potential. In this episode of Trends from the Trenches, Stan Gloss speaks with Jarrod Anderson, Senior Director of Artificial Intelligence at ADM, who discuss…
  continue reading
 
In this episode of Trends from the Trenches, Stan Gloss speaks with Efosa Ojomo, director of the Global Prosperity Group at the Clayton Christensen Institute (CCI) and coauthor of The Prosperity Paradox: How Innovation Can Lift Nations Out of Poverty, about the parallels between consumption economy and life sciences research. Ojomo discusses how re…
  continue reading
 
Bryn Roberts has spent thirty years in informatics and data, most recently at Roche and before that at AstraZeneca. Now as Global Head of Data and Analytics at Roche Information Solutions, Roberts applies his career-long learnings to the current era of data in life sciences, offering advice for building data citizenship, creating a FAIR data cultur…
  continue reading
 
At Pfizer, AI plays a key role in every step of the drug discovery process, Anastasia Christianson, Global Head of AI, ML, Analytics, and Data at Pfizer, tells Stan Gloss on the latest episode of the Trends from the Trenches podcast. Christianson lists the areas at Pfizer where AI is in play and for which she has AI/ML responsibility: research and …
  continue reading
 
Kjiersten Fagnan is an applied mathematician enamored of biology’s messy datasets. Now, as chief informatics officer at the Department of Energy Joint Genome Institute (JGI), located at Lawrence Berkeley National Laboratory, she finds bioinformatics' computational and data challenges very different from applied math or partial differential equation…
  continue reading
 
The steel industry is not a common birthplace of biotech companies, but Andrew Hopkins traces the ideas that became Exscientia back to his time there. New technologies and new processes replaced nearly 90% of the steel workforce, and Hopkins kept those market lessons. He says, “When I ended up in pharma and biotech, I had a very different perceptio…
  continue reading
 
After ten years of working on a specific disease, Chris Gibson’s graduate school lab tested their treatment theory on an animal model. It not only didn’t work, it actually made the animals worse. The experience prompted Gibson to look into how other tools and techniques could be brought to bear on biological programs. And so he quit medical school …
  continue reading
 
Terry Lo has been in healthcare for almost 25 years, with business and commercial roles across pharma, diagnostics, and life sciences, but his most recent role—CEO at Vizgen—connects him with what he calls, “without a doubt the most exciting space I’ve been involved with.” In this episode, Lo speaks with BioTeam’s Stan Gloss about spatial biology, …
  continue reading
 
Host Stan Gloss, founder of BioTeam, talks with Aaron Friedman, HealthAI Principal Product Manager at Amazon Web Services, about the launch of Amazon Omics. This new purpose-built service helps healthcare and life science organizations store, query, and analyze genomic, transcriptomic, and other omics data to generate insights that improve health a…
  continue reading
 
Host Stan Gloss, founder of BioTeam, invites Mike Tarselli, chief scientific officer at TetraScience, to chat about data and how the life sciences industry thinks about our primary product. They discuss the tech sector’s influence on pharma in switching from a project mindset that yields outputs to a product mindset that yields outcomes and why the…
  continue reading
 
Graphene has quickly become a biotech buzzword as scientists aim to better connect with biology and usher in a new wave of technological advancements. Outperforming silicon at nearly every turn, graphene is one of the most biocompatible tools for extracting valuable information without disrupting biological systems. “Graphene is a single layer of c…
  continue reading
 
In the latest episode of Bio-IT World’s Trends from the Trenches podcast, host Stan Gloss, founder of BioTeam, talks with Fernanda Foertter, director of developer relations at Voltron Data, about her AI experiences in the past few years, whether we’ve made any real progress, and if she thinks AI is a pipe dream. “It feels like it’s a pipe dream to …
  continue reading
 
Victoria Gamerman’s love of analytics and math came from her grandmother—the first mathematician she knew. And in her nearly decade at Boehringer Ingelheim, she’s been putting that love to use as the Global Head of Data Governance and Insights. In the latest episode of Bio-IT World’s Trends from the Trenches podcast, host Stan Gloss, founder of Bio…
  continue reading
 
Neurodiversity is inconvenient in a classroom; George Church knows firsthand. But in the latest episode of Bio-IT World’s Trends from the Trenches podcast, Church tells host, Stan Gloss: “I’m interested in overcoming the inconvenience of having people who are a little bit out on the bell curve… You don’t want necessarily to train everybody in your …
  continue reading
 
Susan Gregurick, Associate Director for Data Science and Director of the Office of Data Science Strategy at the National Institutes of Health (NIH), speaks with Stan Gloss, podcast host and BioTeam founder, about the next iteration of the NIH Strategic Plan for Data Science and the lessons learned from the recent pandemic. “COVID just told us how m…
  continue reading
 
Dr. Kim Branson’s intense interest in drug discovery and structural biology quickly led to an interest in machine learning. After receiving multiple degrees from esteemed universities in Australia, Branson trained at Stanford and now works as the Senior Vice President and Global Head of AI/ML at GSK. With host, Stan Gloss, Branson shares his work i…
  continue reading
 
James Cuff summarizes his career over the past 25 years or so in the latest episode of Bio-IT World’s Trends from the Trenches podcast. He tells our host, BioTeam’s Stan Gloss, where he’s seen updates in the space and which things have fundamentally stayed the same. He also shares about the problem that’s been bugging him for the past five years an…
  continue reading
 
Jim Bilotta found his home in orphan diseases early in his career, driven by both personal experience and the “unbelievable” impact on patients and their families. Today, as Chief Information Officer, head of IT, at Alnylam, he is still pursuing that impact. Bilotta and Trends from the Trenches host, Stan Gloss, discuss digital transformation at Al…
  continue reading
 
Bio-IT World and BioTeam have been exploring the drivers of life sciences innovation for years during the Bio-IT World Conference & Expo and in regular columns in the publication. Now Bio-IT World editor, Allison Proffitt, and BioTeam co-founder, Stan Gloss, discuss their latest project: a podcast to capture in-depth conversations with leaders in t…
  continue reading
 
At the National Cancer Institute, Tony Kerlavage knows quite a bit about managing very large pools of data. When NCI launched the Genomic Data Commons, it aimed to democratize access to the genomic data in The Cancer Genome Atlas and other sources. Since then, though, Kerlavage points out that our data types and volumes have only grown. Now NCI is …
  continue reading
 
From big pharma to Amazon Web Services, Lita Sands has seen the amazing impact that the Cloud has had on life sciences research over the course of her career. During the pandemic, Sands has seen companies’ journeys to the cloud accelerate from 8-12 year roadmaps into 1-2 year transition plans. As companies turn their attention to enabling digital t…
  continue reading
 
Loading …

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play